🌟 Pharmidex is proud to attend the Creative Disruption Forum! 🌟
December 11, 2024
We are excited to participate in the Creative Disruption Forum: How Tech is Changing Small Molecule Drug Hunting, taking place on Thursday, 12 December at MAYDE, 5-10 Brandon Road, London N7 9AA.
Representing
Pharmidex will be our Head of Operations,
Ash Alavijeh, and
Mohammed Yaqoob, from Business Development. They are looking forward to engaging with all attendees to explore opportunities for future collaborations with companies, research groups, and universities.
This forum is an incredible opportunity to connect, share ideas, and discuss how technological innovation is revolutionizing small molecule drug discovery. Let’s shape the future of science together! 🚀
We would be delighted to meet you there. Feel free to reach out or stop by for a chat!


At Pharmidex, we are proud to contribute to scientific innovation through robust and reliable bioanalytical support from early discovery to regulated studies. For over eight years, we've partnered with Shimadzu, using their LCMS-8060 and LC-2050 systems to deliver high-quality, data-driven results tailored to diverse client needs. Their instruments have played a key role in advancing our bioanalytical capabilities and supporting the success of our collaborative projects. Our Head of Operations, Ash Alavijeh , recently shared insights from our long-standing collaboration as part of Shimadzu’s 150th anniversary testimonial series. We are honored to be part of their journey and look forward to continuing this partnership built on shared values of precision, reliability, and innovation. 👉 Read more stories from the Shimadzu global community here .

At Pharmidex, we stand in solidarity with individuals and families affected by Huntington’s Disease a rare, inherited neurodegenerative condition that impacts the mind, body, and spirit. Throughout May, we reaffirm our commitment to advancing neuroscience research and supporting drug discovery efforts aimed at neurodegenerative diseases. Our team is proud to collaborate with partners working toward meaningful therapies that can improve quality of life and bring hope to the HD community. Let’s raise awareness. Let’s drive innovation. Let’s stand together.

We’re pleased to share that Mo Yaqoob from our Business Development team will be attending the C3 Summit on 8 May 2025 at 8 Northumberland Ave, London. 🔗 https://www.thec3summit.com/london-2025/  Mo is looking forward to meeting fellow attendees, exploring new partnerships, and discussing how we can work together to accelerate the development of innovative drug candidates. If you're attending, don’t hesitate to connect let’s spark the next great collaboration!